Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Zhenxiang,Li

第一单位： The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Beijing Cancer Hospital & Institute, Peking University School of Oncology Beijing, China.

作者： Zhenxiang,Li ^[1] ; Leilei,Jiang ^[1] ; Hua,Bai ^[1] ; Zhijie,Wang ^[1] ; Jun,Zhao ^[1] ; Jianchun,Duan ^[1] ; Xiaodan,Yang ^[1] ; Tongtong,An ^[1] ; Jie,Wang ^[1]

作者单位： The Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Thoracic Medical Oncology, Beijing Cancer Hospital & Institute, Peking University School of Oncology Beijing, China. ^[1]

关键词 BRAF mutation EGFR mutation lung adenocarcinomas plasma DNA

DOI 10.1111/1759-7714.12177

PMID 26273372

发布时间 2022-04-09

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览39

Thoracic cancer

2015年6卷3期

269-74页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Prevalence and clinical significance of BRAF V600E in Chinese patients with lung adenocarcinoma.

Thoracic cancer

相似文献

Thoracic cancer

相关期刊

检索历史清除